enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Daratumumab - Wikipedia

   en.wikipedia.org/wiki/Daratumumab

   Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. It binds to CD38 , [ 7 ] which is overexpressed in multiple myeloma cells. [ 8 ]

3. Daratumumab/hyaluronidase - Wikipedia

   en.wikipedia.org/wiki/Daratumumab/hyaluronidase

   It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]

4. Genmab’s Darzalex Gets FDA Approval For Blood ... - AOL

   www.aol.com/news/genmab-darzalex-gets-fda...

   Genmab A/S announced on Jan. 15 that its drug, Darzalex Faspro has been approved by the US Food and Drug Administration (FDA) for the treatment of light-chain (AL) amyloidosis in adult patients ...

5. Common cancer treatment can have this painful side effect - AOL

   www.aol.com/common-cancer-treatment-painful-side...

   During active cancer treatment, patients face many smaller battles on the path to remission.. One of those lesser-known struggles is a condition known as chemo mouth, a painful side effect of ...

6. Genmab Announces Net Sales of DARZALEX® (daratumumab) for ...

   lite.aol.com/tech/story/0022/20241015/1000997514.htm

   COPENHAGEN, Denmark; October 15, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX ® (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO ® in the U.S.), as reported by Johnson & Johnson were USD 3,016 million ...

7. GSK blood cancer drug nearly halves risk of death in late ...

   www.aol.com/news/gsk-blood-cancer-drug-nearly...

   GSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late ...

8. Disulfiram-like drug - Wikipedia

   en.wikipedia.org/wiki/Disulfiram-like_drug

   [1] [2] The reaction has been variously termed a disulfiram-like reaction, alcohol intolerance, and acetaldehyde syndrome. [ 3 ] The prototypical drug of this group is disulfiram (brand name Antabuse), which acts as an acetaldehyde dehydrogenase inhibitor , preventing the metabolism of acetaldehyde into acetic acid , and is used in the ...

9. Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024

   lite.aol.com/tech/story/0022/20250122/1001044358.htm

   COPENHAGEN, Denmark; January 22, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO ® in the U.S.), as reported by J&J were USD 11,670 million in 2024.